IRIS Hook Assisted Phacoemulsification in Vitrectomized Eyes

Sponsor
Second Affiliated Hospital of Xi'an Jiaotong University (Other)
Overall Status
Completed
CT.gov ID
NCT03584139
Collaborator
(none)
62
1
2
21
3

Study Details

Study Description

Brief Summary

Although phacoemulsification in previously vitrectomized eyes is a relatively safe procedure comparing with extracapsular cataract surgery, it is still more challenging than in eyes without previous vitrectomy because of the anatomical differences after PPV. Intraoperative difficulties such as abnormal anterior chamber deepening, unstable posterior capsules, and weakened zonules have been reported.

The investigators aim to evaluate the efficacy and safety of a new simple iris hook assisted maneuver in phacoemulsification, then compare the incidence of intraoperative and postoperative complications of this technique with traditional phacoemulsification and phacoemulsification with 25-gauge vitreous irrigation. The latter two surgery methods are currently popular for cataract in vitrectomized eyes.

Condition or Disease Intervention/Treatment Phase
  • Device: IRIS HOOK
  • Device: TRADITION
N/A

Detailed Description

With the continuous evolution in vitrectomy techniques and instrumentation, an increasing number of vitreorential disorders are being successfully managed with pars plana vitrectomy (PPV). Cataract is one of the most common complications seen in phakic patients following PPV, and the incidence of it ranges from 4 to 80%, even up to 100% in various studies.

Although phacoemulsification in previously vitrectomized eyes is a relatively safe procedure comparing with extracapsular cataract surgery, it is still more challenging than in eyes without previous vitrectomy because of the anatomical differences after PPV. Intraoperative difficulties such as abnormal anterior chamber deepening, unstable posterior capsules, and weakened zonules have been reported.

The investigators aim to evaluate the efficacy and safety of a new simple iris hook assisted maneuver in phacoemulsification, then compare the incidence of intraoperative and postoperative complications of this technique with traditional phacoemulsification and phacoemulsification with 25-gauge vitreous irrigation. The latter two surgery methods are currently popular for cataract in vitrectomized eyes.

Study Design

Study Type:
Interventional
Actual Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
IRIS Hook Assisted Phacoemulsification in Vitrectomized Eyes
Actual Study Start Date :
Apr 1, 2018
Actual Primary Completion Date :
Dec 31, 2019
Actual Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: IRIS HOOK

iris hook assisted maneuver in phacoemulsification

Device: IRIS HOOK
iris hook assisted maneuver in phacoemulsification

Active Comparator: TRADITION

traditional phacoemulsification or phacoemulsification with 25-gauge vitreous irrigation

Device: TRADITION
traditional phacoemulsification or phacoemulsification with 25-gauge vitreous irrigation

Outcome Measures

Primary Outcome Measures

  1. Stability of anterior chamber and pupil [Intraoperative]

    The traditional phacoemulsification in vitrectomized eyes usually with more Intraoperative difficulties such as abnormal anterior chamber deepening and unstable pupil. To evaluate whether the new method will increase the stability of anterior chamber and pupil.

  2. Time of operation [Intraoperative]

    To evaluate whether the new method will shorten the operation time

  3. Cumulative dissipated energy (CDE) [Intraoperative]

    To evaluate whether the new method will decrease CDE. CDE reflect the damage of phacoemulsification to the eye, It can be acquired automatically from the phacoemulsification machine. The unit of CDE is mJ.

Secondary Outcome Measures

  1. The presence of intraoperative complications [Intraoperative]

    The incidence of complications, including infusion deprivation syndrome, anterior capsulorhexis extension, iris trauma, descemets detachment, posterior capsular defect, nucleus drop, etc

  2. Visual acuity (VA) [3 months after opreation]

    To evaluate whether the surgery can effectively increase VA.

  3. Intraocular pressure(IOP) [3 months after opreation]

    The traditional phacoemulsification in vitrectomized eyes usually cause low IOP in the early stage, and sometimes induce detachment of choroid. To evaluate whether the new method will avoid the low IOP in the early stage.

  4. The presence of postoperative complications [3 months after opreation]

    The incidence of complications, including corneal edema, cystoid macular edema, etc.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. patients with visually significant cataract following PPV

  2. After PPV vitreous substitutes were air / gas (Perfluoropropane:C3F8) or BSS,

  3. After PPV if vitreous substitute was silicone oil, that should be removed at least 3 months.

  4. The duration between PPV / silicone oil remove and phacoemulsification should more than 3 months

  5. Willing and able to comply with clinic visits and study-related procedures

  6. Provide signed informed consent

Exclusion Criteria:
  1. Eyes with a history of acute angle-closure glaucoma, trauma,

  2. Eyes with a clinically dislocated or subluxated lens.

  3. Active ocular or periocular infection in the study eye

  4. Uncontrolled Blood Pressure

  5. Pregnant or breast-feeding women

  6. Participation in another simultaneous medical investigator or trial

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Ophthalmology, Second affiliated hospital of Xian Jiaotong University Xi'an Shaanxi China 710004

Sponsors and Collaborators

  • Second Affiliated Hospital of Xi'an Jiaotong University

Investigators

  • Principal Investigator: Ling Bai, MD,PhD, Second affiliated hospital of Xian Jiaotong University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bai Ling, Associated Professor, Second Affiliated Hospital of Xi'an Jiaotong University
ClinicalTrials.gov Identifier:
NCT03584139
Other Study ID Numbers:
  • IRIS hook
First Posted:
Jul 12, 2018
Last Update Posted:
Mar 6, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 6, 2020